CAR-T cell update: Therapy improves outcomes for patients with B-cell lymphoma
Forty percent of patients with diffuse large B-cell lymphoma had a complete response, most of which were durable In their ...
Tag: Pharmaceutical Science
Global trial shows CAR T therapy can lead to durable remissions in non-Hodgkin's lymphoma
Updated data on JULIET trial presented at ASH Annual Meeting PHILADELPHIA - In an update to a global clinical trial ...
Sickle cell anemia treatment safely lowers disease burden in African children
Daily hydroxyurea pill helps kids batting disease lead healthier livesCredit: Cincinnati Children's CINCINNATI - A daily hydroxyurea pill may finally ...
POPULAR NEWS
-
Overlooked Dangers: Debunking Common Myths About Skin Cancer Risk in the U.S.
-
AI Achieves Breakthrough in Drug Discovery by Tackling the True Complexity of Aging
-
USF Research Unveils AI Technology for Detecting Early PTSD Indicators in Youth Through Facial Analysis
-
Dr. Miriam Merad Honored with French Knighthood for Groundbreaking Contributions to Science and Medicine